Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Health
Biotech
Pharmalot
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

Startup Spotlight: Running blood tests in a post-Theranos world

  • Damian Garde

By Damian Garde March 8, 2017

Reprints
STAT SPOTLIGHT
Alex Hogan/STAT

Meet Provista Diagnostics, an upstart company promising to divine potentially life-saving information from a blood draw.

If that description makes you think of a certain de-horned unicorn, you’re not alone.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Tags

5 ways to address the shortage of health care…
5 ways to address the shortage of health care workers
‘Health equity tourists’: How white scholars are colonizing research…
‘Health equity tourists’: How white scholars are colonizing research on health disparities
Why you get paid to donate plasma but not…
Why you get paid to donate plasma but not blood
Biden administration goes easy on Medicare Advantage insurers after…
Biden administration goes easy on Medicare Advantage insurers after intense industry lobbying
European Union drug pricing proposal for the pandemic treaty…
European Union drug pricing proposal for the pandemic treaty generates pushback
Inflation caused a sizable drop in net drug prices…
Inflation caused a sizable drop in net drug prices in late 2022, analysis finds

Recommended Stories